RESUMO
BACKGROUND: Chikungunya is associated with high morbidity and the natural history of symptomatic infection has been divided into three phases (acute, post-acute, and chronic) according to the duration of musculoskeletal symptoms. Although this classification has been designed to help guide therapeutic decisions, it does not encompass the complexity of the clinical expression of the disease and does not assist in the evaluation of the prognosis of severity nor chronic disease. Thus, the current challenge is to identify and diagnose musculoskeletal disorders and to provide the optimal treatment in order to prevent perpetuation or progression to a potentially destructive disease course. METHODS: The study is the first product of the Clinical and Applied Research Network in Chikungunya (REPLICK). This is a prospective, outpatient department-based, multicenter cohort study in Brazil. Four work packages were defined: i. Clinical research; ii) Translational Science - comprising immunology and virology streams; iii) Epidemiology and Economics; iv) Therapeutic Response and clinical trials design. Scheduled appointments on days 21 (D21) ± 7 after enrollment, D90 ± 15, D120 ± 30, D180 ± 30; D360 ± 30; D720 ± 60, and D1080 ± 60 days. On these visits a panel of blood tests are collected in addition to the clinical report forms to obtain data on socio-demographic, medical history, physical examination and questionnaires devoted to the evaluation of musculoskeletal manifestations and overall health are performed. Participants are asked to consent for their specimens to be maintained in a biobank. Aliquots of blood, serum, saliva, PAXgene, and when clinically indicated to be examined, synovial fluid, are stored at -80° C. The study protocol was submitted and approved to the National IRB and local IRB at each study site. DISCUSSION: Standardized and harmonized patient cohorts are needed to provide better estimates of chronic arthralgia development, the clinical spectra of acute and chronic disease and investigation of associated risk factors. This study is the largest evaluation of the long-term sequelae of individuals infected with CHIKV in the Brazilian population focusing on musculoskeletal manifestations, mental health, quality of life, and chronic pain. This information will both define disease burden and costs associated with CHIKV infection, and better inform therapeutic guidelines.
Assuntos
Febre de Chikungunya , Humanos , Febre de Chikungunya/diagnóstico , Febre de Chikungunya/epidemiologia , Febre de Chikungunya/terapia , Estudos de Coortes , Estudos Prospectivos , Qualidade de Vida , Doença Crônica , Estudos Multicêntricos como AssuntoRESUMO
BACKGROUND: Studies indicate that different parts of Carica papaya Linn have nutritional properties that mean it can be used as an adjuvant for the treatment of various pathologies. METHODS: The fatty acid composition of the oil extracted from the seeds of Carica papaya Linn was evaluated by gas chromatography, and an acute toxicity test was performed. For the experiment, Swiss mice were fed a balanced or high-fat diet and supplemented with saline, soybean oil, olive oil, or papaya seed oil. Oral glucose tolerance and insulin sensitivity tests were performed. After euthanasia, adiposity, glycemia, total cholesterol and fractions, insulin, resistin, leptin, MCP-1, TNF-α, and IL-6 and the histology of the liver, pancreas, and adipose tissue were evaluated. RESULTS: Papaya seed oil showed predominance of monounsaturated fatty acids in its composition. No changes were observed in the acute toxicity test. Had lower food intake in grams, and caloric intake and in the area of adipocytes without minimizing weight gain or adiposity and impacting the liver or pancreas. Reductions in total and non-HDL-c, LDL-c, and VLDL-c were also observed. The treatment had a hypoglycemic and protective effect on insulin resistance. Supplementation also resulted in higher leptin and lower insulin and cytokine resistance. CONCLUSIONS: Under these experimental conditions, papaya seed oil led to higher amounts of monounsaturated fatty acids and had hypocholesterolemic, hypotriglyceridemic, and hypoglycemic effects.
Assuntos
Carica , Adiposidade , Animais , Carica/química , LDL-Colesterol , Dieta Hiperlipídica/efeitos adversos , Ácidos Graxos/análise , Ácidos Graxos Monoinsaturados , Hipoglicemiantes/análise , Insulina , Interleucina-6/análise , Leptina , Camundongos , Obesidade , Azeite de Oliva/análise , Resistina , Sementes/química , Óleo de Soja/análise , Fator de Necrose Tumoral alfaRESUMO
This study assessed the anti-inflammatory effects of the essential oil from Piper vicosanum leaves (OPV) and evaluated the toxicological potential of this oil through acute toxicity, genotoxicity and mutagenicity tests. The acute toxicity of OPV was evaluated following oral administration to female rats at a single dose of 2 g/kg b.w. To evaluate the genotoxic and mutagenic potential, male mice were divided into five groups: I: negative control; II: positive control; III: 500 mg/kg of OPV; IV: 1000 mg/kg of OPV; V: 2000 mg/kg of OPV. The anti-inflammatory activity of OPV was evaluated in carrageenan-induced pleurisy and paw edema models in rats. No signs of acute toxicity were observed, indicating that the LD50 of this oil is greater than 2000 mg/kg. In the comet assay, OPV did not increase the frequency or rate of DNA damage in groups treated with any of the doses assessed compared to that in the negative control group. In the micronucleus test, the animals treated did not exhibit any cytotoxic or genotoxic changes in peripheral blood erythrocytes. OPV (100 and 300 mg/kg) significantly reduced edema formation and inhibited leukocyte migration analyzed in the carrageenan-induced edema and pleurisy models. These results show that OPV has anti-inflammatory potential without causing acute toxicity or genotoxicity.
Assuntos
Anti-Inflamatórios/farmacologia , Edema/prevenção & controle , Óleos Voláteis/farmacologia , Piper , Extratos Vegetais/farmacologia , Óleos de Plantas/farmacologia , Pleurisia/prevenção & controle , Administração Oral , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/isolamento & purificação , Anti-Inflamatórios/toxicidade , Carragenina , Quimiotaxia de Leucócito/efeitos dos fármacos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/imunologia , Eritrócitos/efeitos dos fármacos , Eritrócitos/patologia , Feminino , Dose Letal Mediana , Masculino , Camundongos , Testes para Micronúcleos , Óleos Voláteis/administração & dosagem , Óleos Voláteis/isolamento & purificação , Óleos Voláteis/toxicidade , Fitoterapia , Piper/química , Piper/toxicidade , Extratos Vegetais/administração & dosagem , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/toxicidade , Folhas de Planta , Óleos de Plantas/administração & dosagem , Óleos de Plantas/isolamento & purificação , Óleos de Plantas/toxicidade , Plantas Medicinais , Pleurisia/induzido quimicamente , Pleurisia/imunologia , Ratos , Ratos Wistar , Medição de Risco , Fatores de TempoRESUMO
Background: The SARS-CoV virus is a precursor to the SARS-CoV-2 virus (COVID-19) and has caused millions of deaths worldwide. Although exercise can be a non-pharmacological means for the prevention and treatment of various diseases, the effects on COVID-19 patients are not yet completely clear. Aims: The aim of this study was to investigate the relationship between physical exercise and symptoms caused by COVID-19. Methods: The present systematic review was sent for evaluation and received the PROSPERO registration protocol-CRD42021257475. The search for studies related to health and physical exercise was carried out in the following databases; the "National Library in Medicine MEDLINE-Ovid", "Embase", "Web of Science", "SportDiscus-Ebsco", and "Scopus". Results: Ten articles were included in the systematic review and the findings demonstrated the protective effects of physical exercise in patients with COVID-19. These effects were observed both in symptoms and in the period of hospitalization. In addition, the results show that the benefits of physical exercise seem to collaborate both in an individual manner and as an alternative to drug therapy. Finally, it was possible to verify the effect of physical exercise on variables, such as quality of life, cardiorespiratory capacity, and immunological biomarkers, and on the symptoms of the new Coronavirus. Conclusions: It is possible to conclude that physical exercise can be a component for the treatment of COVID-19. In addition, it could help to reduce the symptoms and severity of COVID-19, and may be considered as an adjunct to drug therapy in patients contaminated with SARS-CoV-2.
RESUMO
Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well understood to differentiate mild from severe cases and identify prognostic markers. We evaluated the immune response profile using a total of 71 biomarkers in sera from patients with SARS-CoV-2 infection, confirmed by RT-PCR and controls. We correlated biological marker levels with negative control (C) asymptomatic (A), nonhospitalized (mild cases-M), and hospitalized (severe cases-S) groups. Among angiogenesis markers, we identified biomarkers that were more frequently elevated in severe cases when compared to the other groups (C, A, and M). Among cardiovascular diseases, there were biomarkers with differences between the groups, with D-dimer, GDF-15, and sICAM-1 higher in the S group. The levels of the biomarkers Myoglobin and P-Selectin were lower among patients in group M compared to those in groups S and A. Important differences in cytokines and chemokines according to the clinical course were identified. Severe cases presented altered levels when compared to group C. This study helps to characterize biological markers related to angiogenesis, growth factors, heart disease, and cytokine/chemokine production in individuals infected with SARS-CoV-2, offering prognostic signatures and a basis for understanding the biological factors in disease severity.
Assuntos
COVID-19 , SARS-CoV-2 , Biomarcadores , Quimiocinas , Citocinas , Fator 15 de Diferenciação de Crescimento , Humanos , Mioglobina , Selectina-PRESUMO
Mauritia flexuosa (Buriti) pulp oil contains bioactive substances and lipids that are protective against cardiovascular and inflammatory diseases. We performed physical and chemical analyses to verify its quality and stability. Buriti oil was stable according to the Rancimat test, presenting an induction period of 6.6 h. We evaluated the effect of supplementation with crude buriti oil and olive oil on metabolic parameters in 108 Swiss mice for 90 days. We investigated six groups: extra virgin olive oil (EVOO) 1 and 2 (1000 and 2000 mg/kg), buriti oil (BO) 1 and 2 (1000 and 2000 mg/kg), synergic (S) (BO1 + EVOO1), and control (water dose 1000 mg/kg). The animals were euthanized to examine their blood, livers, and fats. The supplementation did not interfere with food consumption, weight gain, and histological alterations in the liver. Group S showed the strongest relationship with the fractions HDL-c and non-HDL-c, indicating a possible cardioprotective effect. Moreover, we observed significantly higher IL-6 levels in the control, EVOO2, and BO1 groups than in the EVOO1 group. Resistin was also significantly higher for the synergic treatment than for the control. We conclude that BO combined with EVOO could be an excellent food supplement for human consumption.
Assuntos
Arecaceae , Animais , Arecaceae/química , Suplementos Nutricionais , Fígado/metabolismo , Camundongos , Modelos Teóricos , Azeite de Oliva/metabolismo , Óleos de Plantas/químicaRESUMO
Syphilis, an infectious disease considered a global public health concern, can cause stillbirths and neonatal deaths. This highlights the importance of continuous surveillance studies among women of reproductive age. A cross-sectional study was carried out to analyze the prevalence and risk factors associated with Treponema pallidum infection in women assisted by primary health care units in Dourados, a city located in Mato Grosso do Sul State, Brazil, which borders Paraguay. A questionnaire was applied to a population-based sample, blood samples were collected for syphilis testing and multivariable analyses were performed to screen associations with T. pallidum infection. The prevalence of T. pallidum infection was 6.04%. Bivariate analysis showed that women referring multiple sexual partners (c2: 6.97 [p=0.014]), income less 2 minimal wages (c2: 15.93 [p=0.003]), who did not have high school (c2: 12.64 [p=0.005]), and reporting history of STIs (c2: 7.30 [p=0.018]) are more likely to have syphilis. In the multivariate analysis, a highest prevalence ratio was observed in women with income less than 2 minimal wages (PR: 0.96 [95% CI: 0.85 - 0.97]), and who did not have high school (PR: 0.94 [95% CI: 0.90 - 0.98]). In addition, 80% of the women reported irregular use of condoms and 63.89% declared having sexual intercourses with multiple partners, which creates more opportunities for the transmission of the infection. These results highlight the need for healthcare systems to implement initiatives to monitor syphilis screening and the commitment of patients and their sexual partners to the treatment in order to achieve a decrease of new cases.
Assuntos
Sífilis/epidemiologia , Treponema pallidum/isolamento & purificação , Adulto , Idoso , Brasil/epidemiologia , Cidades , Preservativos , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade , Prevalência , Saúde Pública , Estudos Soroepidemiológicos , Sífilis/diagnóstico , Sexo sem ProteçãoRESUMO
BACKGROUND: Dengue is a public health problem, and noncompliance with World Health Organization (WHO) recommendations for blood transfusion components is frequently reported. Moreover, economic impact studies of the WHO recommendations on the use of blood transfusion are scarce. METHODS: We compared the cost and hospitalization time in a prospective observational study, by following hospitalised patients and analysing their medical records from 2010 and March 2016 to December 2017. We divided the patients into two groups: transfused (with or without WHO criteria for transfusion) and not transfused (with or without WHO criteria for transfusion). Generalised linear modelling was performed to identify the variable that could increase the costs and hospital stay. RESULTS: Among 323 patients, 52 were transfused, of whom 52% without criteria (n = 27), and 271 were not transfused, of which 4.4% (n = 12) with criteria. Hospitalisation costs were 41% higher in the transfused group without criteria than in those with criteria (median US$ 674.3 vs US$ 478 p = 0.293). Patients who were not transfused but met the WHO criteria for transfusion (n = 12) had longer mean hospitalisation time than did those who were not transfused (3.8±3.4 days versus 3.6±3.1 days; p = 0.022). The GLM analysis using hospital stay and costs as the dependent variable explained approximately 33.4% (R2 = 0.334) of the hospitalisation time and 79.3% (R2 = 0.793) of costs. Receiving a transfusion increased the hospitalization time by 1.29 days (p = 0.0007; IRR = 1.29), and the costs were 5.1 times higher than those without receiving blood components (IRR = 5.1; p< 0.001; median US$ 504.4 vs US$ 170.7). In contrast, patients who were transfused according to WHO criteria had a reduction in costs of approximately 96% (IRR = 0.044; p<0.001; ß = -3.12) compared to that for those who were not transfused according to WHO criteria (without criteria). CONCLUSION: Transfusion without following WHO recommendations increased the time and cost of hospitalisation.
Assuntos
Transfusão de Sangue/economia , Transfusão de Sangue/métodos , Dengue/economia , Adolescente , Adulto , Idoso , Brasil , Criança , Pré-Escolar , Dengue/sangue , Feminino , Custos Hospitalares , Hospitalização/economia , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Saúde Pública/economiaRESUMO
Introdução: Com a emergência do SARS-CoV-2 foi disponibilizado uma grande quantidade de ferramentas de diagnóstico. Neste contexto, a falta de vacina, de tratamento e o grande número de casos graves e morte, possibilitou a aprovação emergencial de diversos testes, que ainda necessitam de estudos populacionais para seu registro definitivo. Objetivo: Realizar uma revisão de literatura para avaliar as metodologias de diagnóstico disponíveis no Brasil, de acordo com a realidade local de saúde, explorando o momento epidemiológico a complexidade do teste e a finalidade da sua aplicação. Metodologia: Trata-se de um estudo bibliográfico, descritivo do tipo revisão de literatura. Foram utilizadas as seguintes bases de dados científicos para buscas: PUBMED, MEDLINE, LILACS E COCHRANE LIBRARY, através de descritores selecionados na plataforma DECS. Resultados: O cenário de diversos ensaios, baseados em diferentes metodologias, como os testes baseados em RNA viral, em detecção de antígenos virais ou de anticorpos, associados ao conhecimento da história natural do vírus, possibilita uma análise crítica do melhor diagnóstico de acordo com a clínica do paciente, os epidemiológicos, o objetivo do diagnóstico e a acurácia do ensaio. Atualmente, há mudança no padrão imunológico da população e a descrição de tipos e subtipos de SARS-CoV-2 com mudanças gênicas, que podem levar a mudanças na acurácia diagnóstica ou a re-emergência em surtos de doença grave. Conclusão: Ainda é incerto o caminho evolutivo da história natural da Covid-19 e os ensaios diagnósticos estão em diferentes estágios de desenvolvimento, validação e produção e cada tipo de teste tem suas próprias vantagens e desvantagens distintas inerentes a plataforma tecnológica de origem e uma combinação de tipos de testes usados em momentos diferentes pode ser útil para a condução clínica dos pacientes e no controle da pandemia por SARS-CoV-2.
Introduction: With the emergence of SARS-CoV-2, a large number of diagnostic tools were made available. In this context, the lack of vaccine, treatment and the large number of severe cases and death, allowed the emergency approval of several tests, which still require population studies for their definitive registration. Objective: To carry out a literature review to evaluate the diagnostic methodologies available in Brazil, according to the local health reality, exploring the epidemiological moment, the complexity of the test and the purpose of its application. Methodology: This is a bibliographic, descriptive study of the literature review type. The following scientific databases were used for searches: PUBMED, MEDLINE, LILACS AND COCHRANE LIBRARY, through selected descriptors on the DECS platform. Results: The scenario of several tests, based on different methodologies, such as tests based on viral RNA, on detection of viral antigens or antibodies, associated with knowledge of the natural history of the virus, allows a critical analysis of the best diagnosis according to the patient's clinical, epidemiological, diagnostic objective and assay accuracy. Currently, there is a change in the immune pattern of the population and the description of types and subtypes of SARS-CoV-2 with genetic changes, which can lead to changes in diagnostic accuracy or the re-emergence in outbreaks of severe disease. Conclusion: The evolutionary path of the natural history of Covid-19 is still uncertain and diagnostic assays are at different stages of development, validation and production and each type of test has its own distinct advantages and disadvantages inherent in the technology platform of origin and a combination of types of tests used at different times can be useful for the clinical management of patients and in the control of the SARS-CoV-2 pandemic.
Introducción: Con la aparición del SARS-CoV-2, se dispuso de un gran número de herramientas diagnósticas. En este contexto, la falta de vacuna, tratamiento y el gran número de casos graves y muerte, permitieron la aprobación de urgencia de varias pruebas, que aún requieren estudios poblacionales para su registro definitivo. Objetivo: Realizar una revisión bibliográfica para evaluar las metodologías diagnósticas disponibles en Brasil, de acuerdo con la realidad sanitaria local, explorando el momento epidemiológico, la complejidad de la prueba y la finalidad de su aplicación. Metodología: Se trata de un estudio bibliográfico, descriptivo, del tipo revisión de literatura. Para las búsquedas se utilizaron las siguientes bases de datos científicas PUBMED, MEDLINE, LILACS Y COCHRANE LIBRARY, a través de descriptores seleccionados en la plataforma DECS. Resultados: El escenario de varias pruebas, basadas en diferentes metodologías, como pruebas basadas en el ARN viral, en la detección de antígenos virales o anticuerpos, asociado al conocimiento de la historia natural del virus, permite un análisis crítico del mejor diagnóstico de acuerdo con la clínica del paciente, epidemiológica, objetivo diagnóstico y precisión de la prueba. Actualmente, hay un cambio en el patrón inmunológico de la población y la descripción de tipos y subtipos de SARS-CoV-2 con cambios genéticos, que pueden conducir a cambios en la precisión diagnóstica o la reaparición en brotes de enfermedad grave. Conclusiones: El camino evolutivo de la historia natural del Covid-19 es aún incierto y los ensayos de diagnóstico se encuentran en diferentes etapas de desarrollo, validación y producción y cada tipo de prueba tiene sus propias ventajas y desventajas distintas inherentes a la plataforma tecnológica de origen y una combinación de tipos de pruebas utilizadas en diferentes momentos puede ser útil para el manejo clínico de los pacientes y en el control de la pandemia de SARS- CoV-2.
Assuntos
Revisões Sistemáticas como Assunto , Teste Sorológico para COVID-19/métodos , Teste para COVID-19/métodos , Teste de Ácido Nucleico para COVID-19/métodos , Pesquisa sobre Serviços de Saúde , Anticorpos/análise , Antígenos/análiseRESUMO
Objetivo: identificar o perfil de admissões e o impacto nos desfechos de crianças internadas em uma terapia intensiva pediátrica e comparar os escores de gravidade, funcionalidade e de desconforto respiratório avaliados respectivamente pelas escalas (PIM II, FSS e BSA). Métodos: Estudo de caráter descritivo, retrospectivo, quantitativo de amostragem censitária. Ferramentas de avaliação: Pediatric Index of Mortality - PIM II, Functional Status Scoret -FSS, Boletim de Silverman-Andersen -BSA e avaliação de prontuários médicos e assistenciais. Resultados: 257 crianças menores de 12 anos foram incluídas no estudo durante todo o ano de 2019. A maioria 56% (n 143) eram menores de um ano e masculino 64 % (n 164) por causas respiratórias 60,05 % (n 155). A mortalidade foi de 9,8% (n 25), e a quantidade média de dias de ventilação mecânica foi de 4,57 dias ± 1,31. A idade não influenciou na quantidade de dias de ventilação mecânica (p<0.05), e o BSA avaliado isoladamente, não se associou a necessidade imediata de intubação (p<0.05), os pacientes do desfecho óbito ficaram em média 8,88 e ±13,04 dias internados, e no desfecho alta 4,73 ±6,63 dias. O PIM II pode ser utilizado para o risco de óbito (p <0,05) e valores maiores ou iguais a 21,58 % foram associados a óbitos e menores ou iguais a 6,65 % foram associados à alta. A FSS dos 257 pacientes na admissão foram: normal (147), disfunção leve (37), moderada (47) e grave (26); na alta hospitalar a FSS foi: normal (178), leve (21), moderada (25) e grave (8) mostrando que grau de funcionalidade normal e leve na admissão esta significativamente associado com a alta hospitalar (p< 0,001). Conclusão: O escore de gravidade PIM II foram compatíveis com os desfechos óbito ou alta, as variações no escore BSA para necessidade de ventilação mecânica não estão associados com a idade e com grau do escore. A funcionalidade mais adequada na admissão está associada ao desfecho alta, e os pacientes em sua maioria saem funcionais.
Objective: To identify the profile of admissions and the impact on outcomes of children admitted to a pediatric intensive care unit and to compare severity, functionality and respiratory distress scores assessed respectively by the scales (PIM II, FSS and BSA). Methods: This was a descriptive, retrospective, quantitative study with census sampling. Assessment tools: Pediatric Index of Mortality - PIM II, Functional Status Scoret -FSS, Silverman-Andersen Bulletin -BSA and assessment of medical and health care records. Results: 257 children under the age of 12 years were included in the study throughout 2019. The majority 56% (n 143) were under one year and male 64 % (n 164) from respiratory causes 60.05 % (n 155). Mortality was 9.8% (n 25), and the average amount of days on mechanical ventilation was 4.57 days ± 1.31. Age had no influence on the number of days of mechanical ventilation (p<0.05), and the BSA assessed alone was not associated with the immediate need for intubation (p<0.05), the patients in the outcome death were hospitalized for an average of 8.88 ±13.04 days, and in the discharge outcome 4.73 ±6.63 days. The PIM II can be used for the risk of death (p <0.05) and values greater than or equal to 21.58 % were associated with death and less than or equal to 6.65 % were associated with discharge. The FSS of the 257 patients at admission were: normal (147), mild (37), moderate (47) and severe (26) dysfunction; at hospital discharge the FSS was: normal (178), mild (21), moderate (25) and severe (8) showing that the degree of normal and mild functionality at admission was significantly associated with hospital discharge (p < 0.001). Conclusion: The PIM II severity scores were compatible with the outcomes death or discharge, the variations in BSA score for mechanical ventilation need were not associated with age and score level. The most adequate functionality at admission is associated with the outcome discharge, and most patients leave the hospital functional.
Objetivo: Identificar el perfil de ingreso y el impacto en los resultados de los niños ingresados en una unidad de cuidados intensivos pediátricos y comparar las puntuaciones de gravedad, funcionalidad y distrés respiratorio evaluadas respectivamente por las escalas (PIM II, FSS y BSA). Métodos: Se trató de un estudio descriptivo, retros- pectivo y cuantitativo con muestreo censal. Instrumentos de evaluación: Índice de Mor- talidad Pediátrica - PIM II, Functional Status Scoret -FSS, Boletín de Silverman-Ander- sen -BSA y evaluación de historias clínicas y asistenciales. Resultados: 257 niños meno- res de 12 años fueron incluidos en el estudio a lo largo de 2019. La mayoría 56% (n 143) eran menores de un año y varones 64% (n 164) de causas respiratorias 60,05% (n 155). La mortalidad fue del 9,8% (n 25) y la media de días con ventilación mecánica fue de 4,57 días ± 1,31. La edad no influyó en el número de días de ventilación mecánica (p<0,05), y el BSA evaluado por sí solo no se asoció con la necesidad inmediata de intu- bación (p<0,05), los pacientes en el resultado muerte estuvieron hospitalizados una media de 8,88 ±13,04 días, y en el resultado alta 4,73 ±6,63 días. El PIM II se puede utilizar para el riesgo de muerte (p <0,05) y los valores mayores o iguales a 21,58 % se asociaron con la muerte y menores o iguales a 6,65 % se asociaron con el alta. La SFS de los 257 pacientes al ingreso fue: normal (147), disfunción leve (37), moderada (47) y grave (26); al alta hospitalaria la SFS fue: normal (178), leve (21), moderada (25) y grave (8) mos- trando que el grado de funcionalidad normal y leve al ingreso se asoció significativamente con el alta hospitalaria (p < 0,001). Conclusiones: Las puntuaciones de gravedad del PIM II fueron compatibles con los resultados muerte o alta hospitalaria, las variaciones en la puntuación del BSA para la necesidad de ventilación mecánica no se asociaron con la edad y el nivel de puntuación. La funcionalidad más adecuada al ingreso se asocia con el resultado alta, y la mayoría de los pacientes salen del hospital funcionales.
RESUMO
This study describes the molecular characteristics and risk factors associated with carbapenem-resistant Klebsiella pneumoniae strains. Risk factors associated with KPC-producing K. pneumoniae strains were investigated in this case-control study from May 2011 to May 2013. Bacterial identification was performed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial susceptibility was determined by broth microdilution. Carbapenemase production was assessed by both modified Hodge test (MHT) and ertapenem hydrolysis using MALDI-TOF MS. The presence of ß-lactamase-encoding genes was evaluated by PCR and DNA sequencing. Alterations in genes encoding K. pneumoniae outer membrane proteins were analysed by PCR and DNA sequencing as well as SDS-PAGE. Genetic relatedness among strains was determined by pulsed-field gel electrophoresis. This study included 94 patients. Longer hospitalisation, mechanical ventilation, catheters, and previous surgery were associated with KPC-producing K. pneumoniae. Sixty-eight strains showed resistance to carbapenems. Carbapenemase production was detected by MHT in 67 K. pneumoniae strains and by MALDI-TOF MS in 57. The presence of the blaKPC-2 gene was identified in 57 strains. The blaKPC-2 gene was not found in 11 carbapenem-resistant K. pneumoniae; instead, the blaCTX-M-1-like, blaCTX-M-2-like, blaCTX-M-8 like, blaCTX-M-14-like and blaSHV- like genes associated with OmpK35 and OmpK36 alterations were observed. Thirty-three KPC-producing K. pneumoniae strains were clonally related, and patients infected with these strains had a higher mortality rate (78.78 %). Our results show that KPC-producing K. pneumoniae was associated with several healthcare-related risk factors, including recent surgery.
Assuntos
Infecções por Klebsiella/microbiologia , Klebsiella pneumoniae/enzimologia , Infecção da Ferida Cirúrgica/microbiologia , beta-Lactamases/metabolismo , Estudos de Casos e Controles , Farmacorresistência Bacteriana/genética , Regulação Bacteriana da Expressão Gênica , Regulação Enzimológica da Expressão Gênica , Humanos , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/metabolismo , Pessoa de Meia-Idade , Fatores de Risco , beta-Lactamases/genéticaAssuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Coinfecção/tratamento farmacológico , Infecções por Coronavirus/microbiologia , Farmacorresistência Bacteriana , Pneumonia Viral/microbiologia , Gestão de Antimicrobianos , Infecções Bacterianas/virologia , Betacoronavirus , COVID-19 , Coinfecção/microbiologia , Humanos , Pandemias , SARS-CoV-2RESUMO
BACKGROUND: Dengue, an arboviral disease, is a public health problem in tropical and subtropical regions worldwide. In Brazil, epidemics have become increasingly important, with increases in the number of hospitalizations and the costs associated with the disease. This study aimed to describe the direct costs of hospitalized dengue cases, the financial impact of admissions and the use of blood products where current protocols for disease management were not followed. METHODS AND RESULTS: To analyze the direct costs of dengue illness and platelet transfusion in Brazil based on the World Health Organization (WHO) guidelines, we conducted a retrospective cross-sectional census study on hospitalized dengue patients in the public and private Brazilian health systems in Dourados City, Mato Grosso do Sul State, Brazil. The analysis involved cases that occurred from January through December during the 2010 outbreak. In total, we examined 8,226 mandatorily reported suspected dengue cases involving 507 hospitalized patients. The final sample comprised 288 laboratory-confirmed dengue patients, who accounted for 56.8% of all hospitalized cases. The overall cost of the hospitalized dengue cases was US $210,084.30, in 2010, which corresponded to 2.5% of the gross domestic product per capita in Dourados that year. In 35.2% of cases, blood products were used in patients who did not meet the blood transfusion criteria. The overall median hospitalization cost was higher (p = 0.002) in the group that received blood products (US $1,622.40) compared with the group that did not receive blood products (US $550.20). CONCLUSION: The comparative costs between the public and the private health systems show that both the hospitalization of and platelet transfusion in patients who do not meet the WHO and Brazilian dengue guidelines increase the direct costs, but not the quality, of health care.
Assuntos
Atenção à Saúde/economia , Dengue/economia , Dengue/epidemiologia , Hospitalização/economia , Saúde Pública/economia , Idoso , Brasil/epidemiologia , Custos e Análise de Custo , Estudos Transversais , Dengue/terapia , Surtos de Doenças/economia , Feminino , Custos de Cuidados de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto , Estudos RetrospectivosRESUMO
OBJECTIVE: Piper amalago is used in Brazilian folk medicine as diuretic and for the treatment of urinary calculus disease, although no scientific data have been described to support these effects. Thus, this study aims to evaluate the diuretic effects and antilithiatic activity of the ethanolic extract of P. amalago (EEPam). MATERIALS AND METHODS: Ethanolic extracts of P. amalago (125, 250 and 500mg/kg) were orally administered in male Wistar rats (n=5) and urinary excretion was measured at intervals of up to 24h after administration. The antilithiasic effect of EEPam on calcium oxalate urolithiasis crystallization was examined in a turbidimetric model. RESULTS: The oral administration of all doses of EEPam significantly increased urine output after 24h when compared to control group. Moreover, the application of EEPam, induced an inhibitory effect on calcium oxalate crystallization. CONCLUSIONS: According to results, P. amalago extracts showed diuretic and natriuretic activity and antilithiasic effects.
Assuntos
Diuréticos/análise , Litíase/prevenção & controle , Fitoterapia , Piper/química , Extratos Vegetais/uso terapêutico , Animais , Avaliação Pré-Clínica de Medicamentos , Feminino , Voluntários Saudáveis , Humanos , Masculino , Plantas Medicinais/química , Ratos WistarAssuntos
Galinhas/microbiologia , Farmacorresistência Bacteriana Múltipla/genética , Carne/microbiologia , Salmonella enterica/genética , Salmonella enterica/isolamento & purificação , Sorogrupo , beta-Lactamases/genética , Animais , Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Brasil , DNA Bacteriano/análise , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Genes Bacterianos/genética , Tamanho do Genoma , Genoma Bacteriano , Testes de Sensibilidade Microbiana , Tipagem de Sequências Multilocus , Filogenia , Salmonella enterica/classificação , Salmonella enterica/efeitos dos fármacos , Sequenciamento Completo do Genoma/métodosRESUMO
Sexta doença endêmica prioritária no mundo a leishmaniose visceral humano tem um perfil epidemiológico geograficamente distinto. É endêmica em Mato Grosso do Sul, onde as mudanças na história natural da doença são ligadas à ecologia do vetor, à história dos reservatórios humanos e/ou animais e pela interferência antropogênica no ambiente. Objetivo: Contribuir para o Sistema Público de Saúde com a descrição da distribuição geográfica dos vetores e dos casos humanos de leishmaniose visceral americanos no Estado de Mato Grosso do Sul, no período de 1º de janeiro de 1999 a 31 de dezembro de 2014. Materiais e Métodos: Para a análise espaço-temporal foi utilizado método de posicionamento de dados no centroide do polígono de cada município, utilizando o banco de dados geográficos de distribuição fornecida pelo Instituto brasileiro de Geografia e Estatística, dados secundários de casos humanos disponíveis no Sistema de Informação Notificação de Agravos e distribuição dos vectores fornecidos pela Secretaria Estadual de Saúde. Resultados: Nesta pesquisa, foram descritos casos humanos em 61 dos 79 municípios de Mato Grosso do Sul, e mapeada a rota de expansão da doença humana em direção norte e sul. Conclusão: As informações geográficas apresentadas são estratégicas e importantes para o planejamento do controle da doença no estado de Mato Grosso do Sul e que se fez urgentes e necessárias a investigação e avaliação do programa de controle da doença.
Sixth priority endemic disease in the world human visceral leishmaniasis has a geographically distinct epidemiological profile. It is endemic in Mato Grosso do Sul, where changes in the natural history of the disease are linked to the ecology of the vector, the history of human and / or animal reservoirs and anthropogenic interference with the environment. Objective: To contribute to the Public Health System with a description of the geographic distribution of vectors and human cases of American visceral leishmaniasis in the State of Mato Grosso do Sul, from January 1, 1999 to December 31, 2014. Materials and Methods: For the space-temporal data we used in the centroid of the polygon of each municipality, using the geographic distribution database provided by the Brazilian Institute of Geography and Statistics, secondary data of human cases available in the Information System for Notification of Injuries and distribution of vectors provided by the State Department of Health. Results: In this research, human cases were described in 61 of the 79 municipalities of Mato Grosso do Sul, and mapped the route of human disease expansion towards north and south. Conclusion: The geographic information presented is an important strategy for the planning of disease control in the state of Mato Grosso do Sul the investigation and evaluation of the disease control program are urgent and necessary.
Assuntos
Humanos , Animais , Psychodidae , Análise Espaço-Temporal , Insetos Vetores , Leishmaniose Visceral/epidemiologia , Brasil/epidemiologia , Estudos Retrospectivos , Doenças Endêmicas , Sistemas de Informação em SaúdeRESUMO
Chlamydophila abortus (C. abortus) is associated with reproductive problems in cattle, sheep, and goats. Diagnosis of C. abortus using embryonated chicken eggs or immortalized cell lines has a very low sensitivity. Polymerase chain reaction (PCR) assays have been used to detect C. abortus infection in clinical specimens and organ fragments, such as placenta, fetal organs, vaginal secretions, and semen. The aim of this study was to develop a PCR assay for the amplification of an 856-bp fragment of the rRNA gene of the Chlamydiaceae family. The PCR assay was evaluated using organs from 15 mice experimentally infected with the S26/3 reference strain of C. abortus. The results of the rRNA PCR were compared to the results from another PCR system (Omp2 PCR) that has been previously described for the Omp2 (outer major protein) gene from the Chlamydiaceae family. From the 15 C. abortus-inoculated mice, 13 (K=0.84, standard error =0.20) tested positive using the rRNA PCR assay and 9 (K=0.55, standard error=0.18) tested positive using the Omp2 PCR assay. The detection limit, measured using inclusion-forming units (IFU), for C. abortus with the rRNA PCR (1.05 IFU) was 100-fold lower than for the Omp2 PCR (105 IFU). The higher sensitivity of the rRNA PCR, as compared to the previously described PCR assay, and the specificity of the assay, demonstrated using different pathogenic microorganisms of the bovine reproductive system, suggest that the new PCR assay developed in this study can be used for the molecular diagnosis of C. abortus in abortion and other reproductive failures in bovines, caprines, and ovines.
Chlamydophila abortus (C. abortus) é frequentemente associada a distúrbios reprodutivos em bovinos, ovinos e caprinos. Para o diagnóstico, os métodos de cultivo em ovo embrionado de galinha e em células de linhagem contínua apresentam baixa sensibilidade. A reação em cadeia da polimerase (PCR) tem sido utilizada em placenta, órgãos fetais, secreção vaginal e sêmen para o diagnóstico da C. abortus. O objetivo deste trabalho foi desenvolver um sistema de PCR para a amplificação de um fragmento de 856-pb do gene rRNA da família Chlamydiaceae. A PCR foi avaliada em órgãos de 15 camundongos infectados experimentalmente com a estirpe de referência S26/3 da C. abortus. Os resultados foram comparados com os obtidos em outro sistema de PCR, previamente descrito para o gene Omp2 (outer major protein) da família Chlamydiaceae. Dos 15 camundongos inoculados com C. abortus, 13 (K=0,84, erro padrão=0,20) foram positivos na rRNA PCR e nove (K=0,55, erro padrão=0,18) na Omp2 PCR. O limite de detecção da C. abortus na rRNA PCR (1,05 UFI) foi 100 vezes inferior à Omp2 PCR (105 UFI). A maior sensibilidade em comparação ao sistema de PCR anteriormente descrito, bem como a especificidade demonstrada frente a diferentes microrganismos patogênicos do sistema reprodutivo, abrem a perspectiva da utilização da PCR desenvolvida nesse estudo para o diagnóstico molecular da C. abortus em casos de abortamentos e outros distúrbios reprodutivos em bovinos, ovinos e caprinos.